Athira Pharma Announces Promotion of Kevin Church, Ph.D., to Chief Scientific Officer

January 31, 2023

https://www.globenewswire.com/news-release/2023/01/31/2598239/0/en/Athira-Pharma-Announces-Promotion-of-Kevin-Church-Ph-D-to-Chief-Scientific-Officer.html

BOTHELL, Wash., Jan. 31, 2023 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ:ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the promotion of Kevin Church, Ph.D., to Chief Scientific Officer.

Read more at globenewswire.com

Related news for (ATHA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.